Targeted Overexpression of Luteinizing Hormone in Transgenic Mice Leads to Infertility, Polycystic Ovaries, and Ovarian Tumors

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1995 Feb 28

PMID 7877975

Citations 73

Authors

K A Risma

C M Clay

T M Nett

T Wagner

J Yun

J H Nilson

Affiliations

Soon will be listed here.

Abstract

Hypersecretion of luteinizing hormone (LH) is implicated in infertility and miscarriages in women. A lack of animal models has limited progress in determining the mechanisms of LH toxicity. We have recently generated transgenic mice expressing a chimeric LH beta subunit (LH beta) in gonadotropes. The LH beta chimera contains the C-terminal peptide of the human chorionic gonadotropin beta subunit. Addition of this peptide to bovine LH beta resulted in a hormone with a longer half-life. Furthermore, targeted expression of the LH beta chimera led to elevated LH levels and infertility in female transgenics. These mice ovulated infrequently, maintained a prolonged luteal phase, and developed pathologic ovarian changes such as cyst formation, marked enlargement of ovaries, and granulosa cell tumors. Testosterone and estradiol levels were increased compared to nontransgenic littermates. An unusual extragonadal phenotype was also observed: transgenic females developed hydronephropathy and pyelonephritis. The pathology observed demonstrates a direct association between abnormal secretion of LH and infertility and underscores the utility of the transgenic model for studying how excess LH leads to cyst formation, ovarian tumorigenesis, and infertility.

Citing Articles

Pharmacogenomic of LH and its receptor: are we ready for clinical practice?.

Conforti A, Di Girolamo R, Guida M, Alviggi C, Casarini L Reprod Biol Endocrinol. 2025; 23(Suppl 1):29.

PMID: 40001128 PMC: 11863420. DOI: 10.1186/s12958-025-01359-2.

Mechanism of female CHH caused by compound heterozygous mutations in the LHB gene.

Ma H, Li C, Gao J, Wu W, Sun Z, Wang X J Assist Reprod Genet. 2025; 42(1):293-302.

PMID: 39786527 PMC: 11806124. DOI: 10.1007/s10815-024-03307-2.

Postnatal Ovarian Transdifferentiation in the Absence of Estrogen Receptor Signaling Is Dependent on Genetic Background.

Binder A, Burns K, Rodriguez K, Hamilton K, Pardo-Manuel de Villena F, Korach K Endocrinology. 2024; 166(1).

PMID: 39576259 PMC: 11630523. DOI: 10.1210/endocr/bqae157.

Transgenic Expressing Active Human LH Receptor in the Gonads Exhibit a Decreased Fecundity: Towards a Platform to Identify New Orally Active Modulators of Gonadotropin Receptor Activity.

Mahamid A, Ben-Menahem D Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458908 PMC: 11510345. DOI: 10.3390/ph17101267.

Polysaccharide-fecal microbiota-based colon-targeted self-nanoemulsifying drug delivery system of curcumin for treating polycystic ovarian syndrome.

Corrie L, Singh H, Gulati M, Vishwas S, Chellappan D, Gupta G Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):6721-6743.

PMID: 38507103 DOI: 10.1007/s00210-024-03029-3.

References

Franks S . Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf). 1989; 31(1):87-120. DOI: 10.1111/j.1365-2265.1989.tb00457.x. View

Gibson M, Miller G, Silverman A . Pulsatile luteinizing hormone secretion in normal female mice and in hypogonadal female mice with preoptic area implants. Endocrinology. 1991; 128(2):965-71. DOI: 10.1210/endo-128-2-965. View

Kumar T, Low M . Gonadotrope-specific expression of the human follicle-stimulating hormone beta-subunit gene in pituitaries of transgenic mice. Mol Endocrinol. 1992; 6(1):81-90. DOI: 10.1210/mend.6.1.1738375. View

Andriole V, COHN G . THE EFFECT OF DIETHYLSTILBESTROL ON THE SUSCEPTIBILITY OF RATS TO HEMATOGENOUS PYELONEPHRITIS. J Clin Invest. 1964; 43:1136-45. PMC: 289595. DOI: 10.1172/JCI104998. View

Shoham Z, Jacobs H, INSLER V . Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril. 1993; 59(6):1153-61. DOI: 10.1016/s0015-0282(16)55968-8. View

Kendall S, Saunders T, Jin L, Lloyd R, Glode L, Nett T . Targeted ablation of pituitary gonadotropes in transgenic mice. Mol Endocrinol. 1991; 5(12):2025-36. DOI: 10.1210/mend-5-12-2025. View

BISKIND G, Bernstein D, Gospe S . The effect of exogenous gonadotrophins on the development of experimental ovarian tumors in rats. Cancer Res. 1953; 13(3):216-20. View

Matzuk M, Hsueh A, Lapolt P, Tsafriri A, Keene J, Boime I . The biological role of the carboxyl-terminal extension of human chorionic gonadotropin [corrected] beta-subunit. Endocrinology. 1990; 126(1):376-83. DOI: 10.1210/endo-126-1-376. View

Kaetzel D, Browne J, Wondisford F, Nett T, Thomason A, Nilson J . Expression of biologically active bovine luteinizing hormone in Chinese hamster ovary cells. Proc Natl Acad Sci U S A. 1985; 82(21):7280-3. PMC: 390833. DOI: 10.1073/pnas.82.21.7280. View

10.

Farookhi R, Hemmings R, Brawer J . Unilateral ovariectomy restores ovulatory cyclicity in rats with a polycystic ovarian condition. Biol Reprod. 1985; 32(3):530-40. DOI: 10.1095/biolreprod32.3.530. View

11.

Fares F, Suganuma N, Nishimori K, Lapolt P, Hsueh A, Boime I . Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc Natl Acad Sci U S A. 1992; 89(10):4304-8. PMC: 49070. DOI: 10.1073/pnas.89.10.4304. View

12.

Niswender G, MIDGLEY Jr A, MONROE S, REICHERT Jr L . Radioimmunoassay for rat luteinizing hormone with antiovine LH serum and ovine LH-131-I. Proc Soc Exp Biol Med. 1968; 128(3):807-11. DOI: 10.3181/00379727-128-33129. View

13.

Vaitukaitis J, Braunstein G, ROSS G . A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol. 1972; 113(6):751-8. DOI: 10.1016/0002-9378(72)90553-4. View

14.

Polson D, Adams J, Wadsworth J, Franks S . Polycystic ovaries--a common finding in normal women. Lancet. 1988; 1(8590):870-2. DOI: 10.1016/s0140-6736(88)91612-1. View

15.

Karsch F . Central actions of ovarian steroids in the feedback regulation of pulsatile secretion of luteinizing hormone. Annu Rev Physiol. 1987; 49:365-82. DOI: 10.1146/annurev.ph.49.030187.002053. View

16.

Roberts J . Hydronephrosis of pregnancy. Urology. 1976; 8(1):1-4. DOI: 10.1016/0090-4295(76)90041-8. View

17.

Lapthorn A, Harris D, Littlejohn A, Lustbader J, Canfield R, Machin K . Crystal structure of human chorionic gonadotropin. Nature. 1994; 369(6480):455-61. DOI: 10.1038/369455a0. View

18.

Poretsky L . On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev. 1991; 12(1):3-13. DOI: 10.1210/edrv-12-1-3. View

19.

Coney P . Polycystic ovarian disease: current concepts of pathophysiology and therapy. Fertil Steril. 1984; 42(5):667-82. DOI: 10.1016/s0015-0282(16)48189-6. View

20.

SIMMONS D, Voss J, Ingraham H, Holloway J, Broide R, Rosenfeld M . Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev. 1990; 4(5):695-711. DOI: 10.1101/gad.4.5.695. View